mefenamic acid has been researched along with Dysmenorrhea in 59 studies
Mefenamic Acid: A non-steroidal anti-inflammatory agent with analgesic, anti-inflammatory, and antipyretic properties. It is an inhibitor of cyclooxygenase.
mefenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,3-dimethylphenyl group. Although classed as a non-steroidal anti-inflammatory drug, its anti-inflammatory properties are considered to be minor. It is used to relieve mild to moderate pain, including headaches, dental pain, osteoarthritis and rheumatoid arthritis.
Dysmenorrhea: Painful menstruation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Background The objective was to compare the effectiveness and tolerability of mefenamic acid and celecoxib in women with primary dysmenorrhea (PD) and to compare the quality of life of study participants pre- and post-treatment." | 9.34 | Celecoxib versus mefenamic acid in the treatment of primary dysmenorrhea. ( Abd Ghani, NA; Abdul Manaf, MR; Basri, NI; Mahdy, ZA; Mohamed Ismail, NA, 2020) |
| "Honey and the mefenamic acid capsules led to the same amount of pain relief in women with primary dysmenorrhea." | 9.24 | Comparison of the effect of honey and mefenamic acid on the severity of pain in women with primary dysmenorrhea. ( Amiri Farahani, ËL; Hasanpoor-Azghdy, SB; Heidari, T; Kasraei, H, 2017) |
| " polium was as effective as mefenamic acid in decreasing the pain severity in primary dysmenorrhea." | 9.22 | Comparison the effect of mefenamic acid and Teucrium polium on the severity and systemic symptoms of dysmenorrhea. ( Abadian, K; Abbasi, NM; Alavi Majd, H; Keshavarz, Z; Mojab, F, 2016) |
| "The aim of the study was to compare the effect of mefenamic acid and ginger on pain management in primary dysmenorrhea." | 9.20 | The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial. ( Alipour, A; Motahari-Tabari, N; Shirvani, MA, 2015) |
| "To compare the effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea." | 9.14 | Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. ( Goli, M; Moattar, F; Ozgoli, G, 2009) |
| "5 mg and 15 mg showed a similar profile in pain reduction and dysmenorrhea symptoms when compared with mefenamic acid." | 9.11 | Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. ( Baracat, EC; Barbosa, IC; Bedone, AJ; Camargos, A; Cortes, RJ; de Mello, NR; de Souza, RN; Martinez Alcala, FO; Rumi, DO; Tomaz, G; Velasco, JA, 2004) |
| "In double-blind studies, mefenamic acid (group A) was compared with ibuprofen (group B) in the treatment of primary dysmenorrhea in 60 patients, during two cycles." | 9.08 | [Treatment of primary dysmenorrhea. Comparative study of ibuprofen and mefenamic acid]. ( Pedrón Nuevo, DN, 1995) |
| "Forty women with moderate to severe primary dysmenorrhea participated in a two-month, double-blind, crossover trial comparing ketoprofen with mefenamic acid." | 9.06 | Double-blind comparison of ketoprofen and mefenamic acid in the treatment of primary dysmenorrhea. ( Bourgouin, J; Hébert, JG; Le Morvan, P, 1986) |
| "The prostaglandin-synthetase inhibitors fluproquazone and mefenamic acid were evaluated for relief of severe primary and secondary IUD-induced dysmenorrhea in a controlled double-blind cross-over study in 48 patients." | 9.05 | [Therapy of dysmenorrhea with prostaglandin synthetase inhibitors: experiences with fluproquazone]. ( Kunz, J; Schneider, W, 1981) |
| "Thirty-five patients (16--23 years old) who had severe primary dysmenorrhea were each treated with 500 mg of mefenamic acid every eight hours for a maximum of three days during menstruation for three consecutive cycles." | 9.05 | Treatment of primary dysmenorrhea with mefenamic acid. ( Coutifaris, B; Kintis, GA, 1980) |
| "Sixty-nine patients with a convincing history of menorrhagia completed a 4-cycle double-blind randomized placebo-controlled crossover trial of mefenamic acid taken during menstruation." | 9.05 | Efficacy of mefenamic acid in patients with a complaint of menorrhagia. ( Elliott, PM; Fraser, IS; Markham, R; McIlveen, J; Pearse, C; Shearman, RP, 1981) |
| " mefenamic acid for the treatment of primary dysmenorrhea." | 7.72 | Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrhea. ( Khabnadideh, S; Namavar Jahromi, B; Tartifizadeh, A, 2003) |
| "A double-blind three-way crossover design in the treatment of dysmenorrhea comparing a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) with a placebo showed that both ibuprofen and mefenamic acid are generally superior to placebo." | 7.66 | A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea. ( Roy, S, 1983) |
| "Telephone interviews with 12 patients (11 had Progestasert IUDs; 1 had copper 7 IUD), who were suffering from dysmenorrhea, were conducted to determine the effects of mefenamic acid in dysmenorrheic patients using IUD." | 7.66 | Mefenamic acid for dysmenorrhea in patients with intrauterine devices. ( Budoff, PW, 1979) |
| "Primary dysmenorrhea is a common gynecologic disorder and is one of the main causes for referral to the gynecology clinic." | 6.90 | Effect of alpha-lipoic acid at the combination with mefenamic acid in girls with primary dysmenorrhea: randomized, double-blind, placebo-controlled clinical trial. ( Hesami, S; Kavianpour, M; Khadem Haghighian, H; Rashidi Nooshabadi, M; Yousefi, M, 2019) |
| "Background The objective was to compare the effectiveness and tolerability of mefenamic acid and celecoxib in women with primary dysmenorrhea (PD) and to compare the quality of life of study participants pre- and post-treatment." | 5.34 | Celecoxib versus mefenamic acid in the treatment of primary dysmenorrhea. ( Abd Ghani, NA; Abdul Manaf, MR; Basri, NI; Mahdy, ZA; Mohamed Ismail, NA, 2020) |
| "Salix extract significantly decreased dysmenorrhea in comparison to mefenamic acid, as the standard treatment of dysmenorrhea." | 5.30 | A double-blind controlled crossover study to investigate the efficacy of salix extract on primary dysmenorrhea. ( Hosseini-Baharanchi, FS; Rafieian-Kopaei, M; Raisi Dehkordi, Z, 2019) |
| "Honey and the mefenamic acid capsules led to the same amount of pain relief in women with primary dysmenorrhea." | 5.24 | Comparison of the effect of honey and mefenamic acid on the severity of pain in women with primary dysmenorrhea. ( Amiri Farahani, ËL; Hasanpoor-Azghdy, SB; Heidari, T; Kasraei, H, 2017) |
| " polium was as effective as mefenamic acid in decreasing the pain severity in primary dysmenorrhea." | 5.22 | Comparison the effect of mefenamic acid and Teucrium polium on the severity and systemic symptoms of dysmenorrhea. ( Abadian, K; Abbasi, NM; Alavi Majd, H; Keshavarz, Z; Mojab, F, 2016) |
| "The aim of the study was to compare the effect of mefenamic acid and ginger on pain management in primary dysmenorrhea." | 5.20 | The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial. ( Alipour, A; Motahari-Tabari, N; Shirvani, MA, 2015) |
| "To compare the effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea." | 5.14 | Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea. ( Goli, M; Moattar, F; Ozgoli, G, 2009) |
| "A single daily dose of etoricoxib, 120 mg, was compared with mefenamic acid (500 mg) every 8 hours and a placebo in a randomized, double-blind, crossover, controlled trial for the relief of moderate and severe pain from secondary dysmenorrhea in 22 women treated over 3 menstrual periods." | 5.12 | Analgesic effect of etoricoxib in secondary dysmenorrhea: a randomized, double-blind, crossover, controlled trial. ( Ranong, CN; Sukcharoen, N, 2007) |
| "5 mg and 15 mg showed a similar profile in pain reduction and dysmenorrhea symptoms when compared with mefenamic acid." | 5.11 | Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea. ( Baracat, EC; Barbosa, IC; Bedone, AJ; Camargos, A; Cortes, RJ; de Mello, NR; de Souza, RN; Martinez Alcala, FO; Rumi, DO; Tomaz, G; Velasco, JA, 2004) |
| "In double-blind studies, mefenamic acid (group A) was compared with ibuprofen (group B) in the treatment of primary dysmenorrhea in 60 patients, during two cycles." | 5.08 | [Treatment of primary dysmenorrhea. Comparative study of ibuprofen and mefenamic acid]. ( Pedrón Nuevo, DN, 1995) |
| "Forty women with moderate to severe primary dysmenorrhea participated in a two-month, double-blind, crossover trial comparing ketoprofen with mefenamic acid." | 5.06 | Double-blind comparison of ketoprofen and mefenamic acid in the treatment of primary dysmenorrhea. ( Bourgouin, J; Hébert, JG; Le Morvan, P, 1986) |
| "A multicenter open crossover study compared piroxicam and mefenamic acid and piroxicam and diclofenac in the treatment of primary dysmenorrhea in 91 patients." | 5.06 | A comparative crossover study of piroxicam vs. mefenamic acid and diclofenac in France. ( Serfaty, D, 1986) |
| "Sixty-nine patients with a convincing history of menorrhagia completed a 4-cycle double-blind randomized placebo-controlled crossover trial of mefenamic acid taken during menstruation." | 5.05 | Efficacy of mefenamic acid in patients with a complaint of menorrhagia. ( Elliott, PM; Fraser, IS; Markham, R; McIlveen, J; Pearse, C; Shearman, RP, 1981) |
| "Thirty-five patients (16--23 years old) who had severe primary dysmenorrhea were each treated with 500 mg of mefenamic acid every eight hours for a maximum of three days during menstruation for three consecutive cycles." | 5.05 | Treatment of primary dysmenorrhea with mefenamic acid. ( Coutifaris, B; Kintis, GA, 1980) |
| "38 patients with dysmenorrhea, aged 21-35 years, were treated with Ponstel (mefenamic acid, a prostaglandin inhibitor)." | 5.05 | Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors. ( Dreher, E; von Fischer, B, 1980) |
| "The prostaglandin-synthetase inhibitors fluproquazone and mefenamic acid were evaluated for relief of severe primary and secondary IUD-induced dysmenorrhea in a controlled double-blind cross-over study in 48 patients." | 5.05 | [Therapy of dysmenorrhea with prostaglandin synthetase inhibitors: experiences with fluproquazone]. ( Kunz, J; Schneider, W, 1981) |
| "In a double-blind corss-over trial, 30 patients experiencing primary dysmenorrhea were treated with 2 prostaglandin inhibitors, mefenamic acid (250mg) and flufenamic acid (100 mg), and an analgesia, dexhropropoxyphene (32." | 5.04 | Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea. ( Anderson, AB; Fraser, IS; Haynes, PJ; Turnbull, AC, 1978) |
| "34 women with recurrent primary dysmenorrhea were given prescriptions for mefenamic acid and told to use it as needed for pain and cramps." | 5.04 | Treatment of dysmenorrhea. ( Budoff, PW, 1977) |
| " mefenamic acid for the treatment of primary dysmenorrhea." | 3.72 | Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrhea. ( Khabnadideh, S; Namavar Jahromi, B; Tartifizadeh, A, 2003) |
| "A double-blind three-way crossover design in the treatment of dysmenorrhea comparing a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) with a placebo showed that both ibuprofen and mefenamic acid are generally superior to placebo." | 3.66 | A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea. ( Roy, S, 1983) |
| "Telephone interviews with 12 patients (11 had Progestasert IUDs; 1 had copper 7 IUD), who were suffering from dysmenorrhea, were conducted to determine the effects of mefenamic acid in dysmenorrheic patients using IUD." | 3.66 | Mefenamic acid for dysmenorrhea in patients with intrauterine devices. ( Budoff, PW, 1979) |
| "The treatment of primary spasmodic dysmenorrhea with prostaglandin synthetase/receptor site inhibitors such as mefenamic acid (Ponstel) is becoming accepted." | 3.66 | Intrauterine pressure changes during dysmenorrhea therapy. ( Powell, JR; Smith, RP, 1982) |
| "Primary dysmenorrhea is considered as one of the women's main problems during reproductive age." | 3.30 | The effect of vitamin D on the severity of dysmenorrhea and menstrual blood loss: a randomized clinical trial. ( Amzajerdi, A; Ghorbali, E; Keshavarz, M; Pezaro, S; Sarvi, F, 2023) |
| "Primary dysmenorrhea is a common gynecologic disorder and is one of the main causes for referral to the gynecology clinic." | 2.90 | Effect of alpha-lipoic acid at the combination with mefenamic acid in girls with primary dysmenorrhea: randomized, double-blind, placebo-controlled clinical trial. ( Hesami, S; Kavianpour, M; Khadem Haghighian, H; Rashidi Nooshabadi, M; Yousefi, M, 2019) |
| "Treatment with mefenamic acid resulted in less volume of blood loss compared to tranexamic acid (MD -64." | 2.82 | Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use. ( Christelle, K; Jaafar, SH; Norhayati, MN, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 36 (61.02) | 18.7374 |
| 1990's | 6 (10.17) | 18.2507 |
| 2000's | 6 (10.17) | 29.6817 |
| 2010's | 5 (8.47) | 24.3611 |
| 2020's | 6 (10.17) | 2.80 |
| Authors | Studies |
|---|---|
| Vahedi, M | 1 |
| Hasanpoor-Azghady, SB | 1 |
| Amiri-Farahani, L | 1 |
| Khaki, I | 1 |
| Christelle, K | 1 |
| Norhayati, MN | 1 |
| Jaafar, SH | 1 |
| Amzajerdi, A | 1 |
| Keshavarz, M | 1 |
| Ghorbali, E | 1 |
| Pezaro, S | 1 |
| Sarvi, F | 1 |
| Basri, NI | 1 |
| Abd Ghani, NA | 1 |
| Mahdy, ZA | 2 |
| Abdul Manaf, MR | 1 |
| Mohamed Ismail, NA | 1 |
| Hesami, S | 2 |
| Kavianpour, M | 2 |
| Rashidi Nooshabadi, M | 2 |
| Yousefi, M | 2 |
| Lalooha, F | 1 |
| Khadem Haghighian, H | 2 |
| Shahrahmani, H | 1 |
| Ghazanfarpour, M | 1 |
| Shahrahmani, N | 1 |
| Abdi, F | 1 |
| Sewell, RDE | 1 |
| Rafieian-Kopaei, M | 2 |
| Amiri Farahani, ËL | 1 |
| Hasanpoor-Azghdy, SB | 1 |
| Kasraei, H | 1 |
| Heidari, T | 1 |
| Raisi Dehkordi, Z | 1 |
| Hosseini-Baharanchi, FS | 1 |
| Shirvani, MA | 1 |
| Motahari-Tabari, N | 1 |
| Alipour, A | 1 |
| Abadian, K | 1 |
| Keshavarz, Z | 1 |
| Mojab, F | 1 |
| Alavi Majd, H | 1 |
| Abbasi, NM | 1 |
| Nor Azlin, MI | 1 |
| Maryasalwati, I | 1 |
| Norzilawati, MN | 1 |
| Jamil, MA | 1 |
| Zainul Rashid, MR | 1 |
| Ozgoli, G | 1 |
| Goli, M | 1 |
| Moattar, F | 1 |
| Namavar Jahromi, B | 1 |
| Tartifizadeh, A | 1 |
| Khabnadideh, S | 1 |
| de Mello, NR | 1 |
| Baracat, EC | 1 |
| Tomaz, G | 1 |
| Bedone, AJ | 1 |
| Camargos, A | 1 |
| Barbosa, IC | 1 |
| de Souza, RN | 1 |
| Rumi, DO | 1 |
| Martinez Alcala, FO | 1 |
| Velasco, JA | 1 |
| Cortes, RJ | 1 |
| Lira-Plascencia, J | 1 |
| Arzola-Paniagua, A | 1 |
| Carranza-Lira, S | 1 |
| Ranong, CN | 1 |
| Sukcharoen, N | 1 |
| Kintis, GA | 1 |
| Coutifaris, B | 1 |
| Budoff, PW | 4 |
| Vairojanavong, K | 1 |
| Limchitti, D | 1 |
| Sasivimolkul, V | 1 |
| Smith, RP | 5 |
| Powell, JR | 4 |
| Fraser, IS | 4 |
| McCarron, G | 1 |
| Markham, R | 2 |
| Owen, PR | 1 |
| Halbert, DR | 1 |
| Langrick, AF | 2 |
| Dreher, E | 1 |
| von Fischer, B | 1 |
| Kunz, J | 1 |
| Schneider, W | 1 |
| Roy, S | 1 |
| Gever, LN | 1 |
| Cooper, SL | 1 |
| Islas Pérez, I | 1 |
| Rodríguez, S | 1 |
| Pearse, C | 1 |
| Shearman, RP | 1 |
| Elliott, PM | 1 |
| McIlveen, J | 1 |
| Dorman, JM | 1 |
| Delgado, J | 1 |
| Simonin, G | 1 |
| Servier, C | 1 |
| García, R | 1 |
| Yoma, J | 1 |
| Pedrón Nuevo, DN | 1 |
| Zhang, WY | 1 |
| Li Wan Po, A | 1 |
| Pedrón-Nuevo, N | 1 |
| González-Unzaga, LN | 1 |
| De Celis-Carrillo, R | 1 |
| Reynoso-Isla, M | 1 |
| de la Torre-Romeral, L | 1 |
| Anderson, AB | 1 |
| Haynes, PJ | 1 |
| Turnbull, AC | 1 |
| Jacobson, J | 1 |
| Cavalli-Björkman, K | 1 |
| Lundström, V | 1 |
| Nilsson, B | 1 |
| Norbeck, M | 1 |
| Harvey, S | 1 |
| Pulkkinen, MO | 1 |
| Kaihola, HL | 1 |
| Souney, PF | 1 |
| Churchill, W | 1 |
| Kaul, AF | 1 |
| Tilyard, MW | 1 |
| Dovey, SM | 1 |
| Long, CC | 1 |
| Finlay, AY | 1 |
| Marks, R | 1 |
| López Rosales, C | 1 |
| Cisneros Lugo, JH | 1 |
| Romo Enciso, LJ | 1 |
| García Sandoval, MG | 1 |
| Gunn, AD | 1 |
| Livesey, H | 1 |
| Whitehead, AM | 1 |
| Zahradnik, HP | 1 |
| Breckwoldt, M | 1 |
| Hébert, JG | 1 |
| Le Morvan, P | 1 |
| Bourgouin, J | 1 |
| Serfaty, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Effect of a Vaginal Ring With Meloxicam on Primary Dysmenorrhea in Women of Childbearing Age[NCT02255045] | Phase 2/Phase 3 | 68 participants (Actual) | Interventional | 2014-06-27 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for mefenamic acid and Dysmenorrhea
| Article | Year |
|---|---|
Interventions to prevent or treat heavy menstrual bleeding or pain associated with intrauterine-device use.
Topics: Acetaminophen; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dysmenorrhea; Female; Hum | 2022 |
Effect of fennel on primary dysmenorrhea: a systematic review and meta-analysis.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dysmenorrhea; Female; Foeniculum; Humans; Mefenamic Acid; P | 2021 |
Efficacy of minor analgesics in primary dysmenorrhoea: a systematic review.
Topics: Acetaminophen; Adolescent; Adult; Analgesics; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, No | 1998 |
37 trials available for mefenamic acid and Dysmenorrhea
| Article | Year |
|---|---|
Comparison of effect of auriculotherapy and mefenamic acid on the severity and systemic symptoms of primary dysmenorrhea: a randomized clinical trial.
Topics: Adolescent; Anti-Inflammatory Agents, Non-Steroidal; Auriculotherapy; Dysmenorrhea; Female; Humans; | 2021 |
The effect of vitamin D on the severity of dysmenorrhea and menstrual blood loss: a randomized clinical trial.
Topics: Adolescent; Adult; Dysmenorrhea; Female; Hemorrhage; Humans; Iran; Mefenamic Acid; Menstruation; Vit | 2023 |
Celecoxib versus mefenamic acid in the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Drug Tolerance; Dysmenorrhea; | 2020 |
Randomized, double-blind, placebo-controlled clinical trial studying the effects of Turmeric in combination with mefenamic acid in patients with primary dysmenorrhoea.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Curcuma; Curcumin; Double-Blind Method; Drug Therapy, Combi | 2021 |
Comparison of the effect of honey and mefenamic acid on the severity of pain in women with primary dysmenorrhea.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Dietary Supplements; Dysmenorrhe | 2017 |
Effect of alpha-lipoic acid at the combination with mefenamic acid in girls with primary dysmenorrhea: randomized, double-blind, placebo-controlled clinical trial.
Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Dysmenorrhea; Female; Humans; Iran; Mefenamic | 2019 |
A double-blind controlled crossover study to investigate the efficacy of salix extract on primary dysmenorrhea.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Dysmenorrhea; Female; Humans; Mefenamic Acid; Plant | 2019 |
The effect of mefenamic acid and ginger on pain relief in primary dysmenorrhea: a randomized clinical trial.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Dysmenorrhea; Female; Hum | 2015 |
Comparison the effect of mefenamic acid and Teucrium polium on the severity and systemic symptoms of dysmenorrhea.
Topics: Adult; Dysmenorrhea; Female; Humans; Iran; Mefenamic Acid; Pain Measurement; Plant Extracts; Teucriu | 2016 |
The efficacy of etoricoxib vs mefenamic acid in the treatment of primary dysmenorrhoea: a randomised comparative trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Cyclooxygenase Inhibitors; Dysme | 2008 |
Comparison of effects of ginger, mefenamic acid, and ibuprofen on pain in women with primary dysmenorrhea.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Dysmenorrhea; Female; Humans; I | 2009 |
Double-blind study to evaluate efficacy and safety of meloxicam 7.5 mg and 15 mg versus mefenamic acid 1500 mg in the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Dose-Response Relationship, Drug; Double | 2004 |
Fenoverine vs. mefenamic acid in the treatment of primary dysmenorrhea.
Topics: Cross-Over Studies; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Humans; Mefenamic Acid; Pain Me | 2006 |
Analgesic effect of etoricoxib in secondary dysmenorrhea: a randomized, double-blind, crossover, controlled trial.
Topics: Adult; Analgesia; Analgesics; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Dy | 2007 |
Treatment of primary dysmenorrhea with mefenamic acid.
Topics: Adolescent; Adult; Drug Evaluation; Dysmenorrhea; Female; Humans; Mefenamic Acid; Placebos | 1980 |
Clinical trial of the efficacy of mefenamic acid in relief of menorrhagia and/or dysmenorrhoea.
Topics: Adolescent; Adult; Clinical Trials as Topic; Dysmenorrhea; Female; Humans; Mefenamic Acid; Menorrhag | 1983 |
Mefenamic acid, ibuprofen, and dysmenorrhea.
Topics: Clinical Trials as Topic; Double-Blind Method; Dysmenorrhea; Female; Humans; Ibuprofen; Mefenamic Ac | 1984 |
A preliminary study of factors influencing perception of menstrual blood loss volume.
Topics: Adult; Age Factors; Clinical Trials as Topic; Double-Blind Method; Dysmenorrhea; Female; Humans; Mef | 1984 |
Prostaglandin synthetase inhibitors in the treatment of primary dysmenorrhea. Outcome trials reviewed.
Topics: Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Flufenamic Acid; Humans; | 1984 |
A study of naproxen sodium and mefenamic acid in primary dysmenorrhoea.
Topics: Adolescent; Adult; Dysmenorrhea; Female; Humans; Mefenamic Acid; Naproxen | 1983 |
Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
Topics: Adult; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Double-Blind Method; Dysmenorrhea; Femal | 1980 |
[Therapy of dysmenorrhea with prostaglandin synthetase inhibitors: experiences with fluproquazone].
Topics: Clinical Trials as Topic; Cyclooxygenase Inhibitors; Dysmenorrhea; Enzyme Inhibitors; Female; Humans | 1981 |
The objective evaluation of dysmenorrhea therapy.
Topics: Clinical Trials as Topic; Double-Blind Method; Dysmenorrhea; Female; Humans; Mefenamic Acid; Placebo | 1980 |
[Mefenamic acid in primary dysmenorrhea].
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Dysmenorrhea; Female; Humans; Mefe | 1981 |
Efficacy of mefenamic acid in patients with a complaint of menorrhagia.
Topics: Adolescent; Adult; Blood Chemical Analysis; Clinical Trials as Topic; Double-Blind Method; Dysmenorr | 1981 |
Tolfenamic acid and mefenamic acid in the treatment of primary dysmenorrhoea.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cross-Over Studies; Double-Blind Method; | 1994 |
[Treatment of primary dysmenorrhea. Comparative study of ibuprofen and mefenamic acid].
Topics: Adolescent; Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Ibuprofen; Mefenamic Acid; Pai | 1995 |
Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea.
Topics: Acetaminophen; Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Dextropropoxyphene | 1978 |
Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience.
Topics: Adolescent; Adult; Clinical Trials as Topic; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Ev | 1979 |
Mefenamic acid in dysmenorrhea.
Topics: Clinical Trials as Topic; Drug Evaluation; Dysmenorrhea; Female; Humans; Mefenamic Acid; Pressure; P | 1977 |
Treatment of dysmenorrhea.
Topics: Clinical Trials as Topic; Double-Blind Method; Dysmenorrhea; Female; Humans; Mefenamic Acid | 1977 |
Use of mefenamic acid in the treatment of primary dysmenorrhea.
Topics: Clinical Trials as Topic; Depression, Chemical; Diagnosis, Differential; Drug Evaluation; Dysmenorrh | 1979 |
A comparison of tiaprofenic acid, mefenamic acid and placebo in the treatment of dysmenorrhoea in general practice.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Dysmenorrhea; Femal | 1992 |
[Nimesulide in the treatment of primary dysmenorrhea. Comparative clinical evaluation with mefenamic acid and fentiazac].
Topics: Acetates; Adult; Anti-Inflammatory Agents, Non-Steroidal; Double-Blind Method; Drug Administration S | 1989 |
A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoea.
Topics: Adolescent; Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Mefenamic Acid; Phenethylamine | 1989 |
Double-blind comparison of ketoprofen and mefenamic acid in the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Clinical Trials as Topic; Double-Blind Method; Dysmenorrhea; Female; Humans; Keto | 1986 |
A comparative crossover study of piroxicam vs. mefenamic acid and diclofenac in France.
Topics: Adult; Clinical Trials as Topic; Diclofenac; Dysmenorrhea; Female; Humans; Mefenamic Acid; Piroxicam | 1986 |
19 other studies available for mefenamic acid and Dysmenorrhea
| Article | Year |
|---|---|
Comparison of fennel and mefenamic acid for the treatment of primary dysmenorrhea.
Topics: Adolescent; Adult; Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Foeniculum; Humans; Mefenamic Ac | 2003 |
Mefenamic acid therapy in dysmenorrhea.
Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Mefenamic Acid; Palliative Care | 1980 |
Menstrual delay and dysfunctional uterine bleeding associated with antiprostaglandin therapy for dysmenorrhea.
Topics: Adult; Dysmenorrhea; Female; Humans; Ibuprofen; Mefenamic Acid; Menstruation Disturbances; Prostagla | 1983 |
Distribution analysis of intrauterine pressure in nonpregnant dysmenorrheic women.
Topics: Adolescent; Adult; Dysmenorrhea; Female; Humans; Manometry; Mefenamic Acid; Microcomputers; Monitori | 1984 |
Dysmenorrhoea: effective new approaches to a controversial problem.
Topics: Cyclooxygenase Inhibitors; Dysmenorrhea; Female; Flufenamic Acid; Humans; Ibuprofen; Indomethacin; M | 1980 |
Intrauterine pressure changes during dysmenorrhea therapy.
Topics: Cyclooxygenase Inhibitors; Double-Blind Method; Dysmenorrhea; Female; Humans; Mefenamic Acid; Pressu | 1982 |
A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea.
Topics: Adult; Double-Blind Method; Dysmenorrhea; Female; Humans; Ibuprofen; Mefenamic Acid; Pain | 1983 |
From arthritis pain to dysmenorrhea: a new indication for prostaglandin inhibitors.
Topics: Arthritis; Dysmenorrhea; Female; Humans; Ibuprofen; Mefenamic Acid; Prostaglandin Antagonists | 1980 |
Dysmenorrhea: a new approach to an old problem.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Dysmenorrhea; Female; Humans; Ibuprofen; Mefenamic Acid; Na | 1981 |
Mefenamic acid for dysmenorrhea in patients with intrauterine devices.
Topics: Dysmenorrhea; Female; Humans; Intrauterine Devices; Mefenamic Acid; Prostaglandins; Uterus | 1980 |
Mefenamic acid for dysmenorrhea.
Topics: Dysmenorrhea; Female; Humans; Mefenamic Acid | 1980 |
[Incidence of dysmenorrhea and associated symptoms in women aged 12-24 years].
Topics: Adolescent; Adult; Age Factors; Aspirin; Child; Dysmenorrhea; Female; Humans; Incidence; Mefenamic A | 1998 |
New relief for menstrual discomfort.
Topics: Dysmenorrhea; Female; Humans; Mefenamic Acid | 1979 |
Primary dysmenorrhoea and flufenamates.
Topics: Dysmenorrhea; Female; Flufenamic Acid; Humans; Mefenamic Acid | 1978 |
Mefenamic acid for dysmenorrhea in patients with intrauterine devices.
Topics: Dysmenorrhea; Female; Humans; Intrauterine Devices; Mefenamic Acid | 1979 |
Drugs for dysmenorrhea.
Topics: Acetaminophen; Aspirin; Dysmenorrhea; Female; Humans; Ibuprofen; Indomethacin; Mefenamic Acid; Nalbu | 1979 |
Mefenamic acid for dysmenorrhea.
Topics: Dysmenorrhea; Female; Humans; Mefenamic Acid; Menstruation; Prostaglandin Antagonists; Time Factors | 1979 |
Fixed drug eruption to mefenamic acid: a report of three cases.
Topics: Adult; Drug Hypersensitivity; Dysmenorrhea; Female; Humans; Mefenamic Acid; Middle Aged; Skin Diseas | 1992 |
[Drug therapy of dysmenorrhea].
Topics: Adrenergic beta-Agonists; Adult; Aspirin; Calcium Channel Blockers; Contraceptives, Oral; Dysmenorrh | 1988 |